Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cedal Pharmaceutical Group is a Turkey-based pharmaceutical company focused on the development, manufacturing, and distribution of high-quality generic medicinal products. The company operates with a focus on providing affordable healthcare solutions across various therapeutic areas, including analgesics, antibiotics, and gastrointestinal treatments. Cedal maintains modern manufacturing facilities that comply with Good Manufacturing Practices (GMP) to ensure the safety and efficacy of its product portfolio. In addition to its domestic operations, the group is active in international markets through strategic exports and partnerships. The company aims to expand its reach by continuously adding new formulations to its pipeline and enhancing its production capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cedal Pharmaceutical Group.